ArticleFrontiers in public health2026
A scoping review and thematic analysis of policy implications of novel and emerging nicotine and tobacco products regulation.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This scoping review aimed to examine policy implications from studies investigating the effectiveness of policies related to novel and emerging nicotine and tobacco products (NENTPs) and to identify commonalities in policy implications for NENTPs through thematic analysis. Methods: This scoping review involved a comprehensive search across the following four databases: PubMed, Embase, Web of Science, and CINAHL. The latest search was on March 15, 2025. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines were followed. Studies were included if they examined the effectiveness of NENTPs-related policies. After screening titles, abstracts, and full texts, 21 studies were selected and analyzed based on the framework to derive policy implications. Results: Most studies were conducted in high-income countries. Thematic analysis yielded the following two analytical themes: (1) regulatory governance and policy system architecture for NENTPs control, which included three descriptive themes-namely, regulatory spillover control in the national context, evidence-informed policy transition and regulation, government monitoring and compliance assurance; and (2) exposure reduction at the population level and societal regulation of NENTPs use, with four descriptive themes-namely, product attribute restrictions as an initiation control, regulation of access to retail stores and exposure to youth, economic restraint through tax increase, and customized communication for policy education. Conclusion: This study highlights that effective legal regulation of NENTPs requires not only regulatory governance and policy systems but also population-level regulatory mechanisms that reinforce the legal foundation. Our findings provide timely, integrated insights for policymakers by examining commonly shared perspectives among policy researchers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.